Abstract
Past
Most prostate cancers are slow growing and are often diagnosed at an old age, which may result in treatment never being needed. However, definitive treatments such as radical prostatectomy and radiation therapy are often associated with many serious adverse effects, harming the physical and mental health of patients.
Present
In recent years, different types of minimally invasive therapy have been developed to achieve cancer control, continence, and even potency preservation, such as high-intensity focused ultrasound (HIFU). HIFU has been proposed for prostate cancer patients to provide an equivalent oncologic result to definitive treatment, with a reduced adverse effect profile, thus increasing the interest in HIFU for the treatment of localized prostate cancer.
Future
Sonablate® HIFU performed an outstanding cancer control in treating localized prostate cancer, with low biochemical recurrence and complication rates. As further long-term follow-up data mature, we anticipate the routine application of HIFU for localized prostate cancer within the next few years.
This is a preview of subscription content, log in via an institution to check access.
References
Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Eastham JA, PT Scardino, MW Kattan. Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol. 2008;179(6):2207–10; discussion 2210-1.
Valerio M, et al. The role of focal therapy in managing localized prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51.
Lin CT, Chiang PH, Tsai MY, Chiang PH, Chiang PC. High-Intensity focused ultrasound (Sonablate®) for prostate cancer: preliminary outcomes in Taiwan. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14250-4.
Mearini L, Porena M. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future. Indian J Urol. 2010;26(1):4–11. https://doi.org/10.4103/0970-1591.60436.
Huang YC, Kan CH, Chiang PH, et al. Salvage radiotherapy plus androgen deprivation therapy for high-risk prostate cancer with biochemical failure after high-intensity focused ultrasound as primary treatment. J Clin Med. 2022;11:4450–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
DISCLOSURE
Mu Yao Tsai, Chih Tai Lin, ** Hsuan Chiang, Po Hui Chiang, and ** Chia Chiang have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tsai, M.Y., Lin, C.T., Chiang, P.H. et al. ASO Author Reflections: High-Intensity Focused Ultrasound will Become the Routine Practice for Treatment of Localized Prostate Cancer. Ann Surg Oncol 30, 8786–8787 (2023). https://doi.org/10.1245/s10434-023-14297-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14297-3